Shriram Ct Scan & Diagnostics Profile
Key Indicators
- Authorised Capital ₹ 7.50 M
as on 13-12-2024
- Paid Up Capital ₹ 7.45 M
as on 13-12-2024
- Company Age 11 Year, 4 Months
- Last Filing with ROC 31 Mar 2023
- Revenue -63.77%
(FY 2023)
- Profit -115.31%
(FY 2023)
- Ebitda -78.80%
(FY 2023)
- Net Worth -3.15%
(FY 2023)
- Total Assets -15.20%
(FY 2023)
About Shriram Ct Scan & Diagnostics
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 7.50 M and a paid-up capital of Rs 7.45 M, as per Ministry of Corporate Affairs (MCA) records.
Prasad Joshi, Girish Kakde, Ratnali Gandhi, and Seven other members serve as directors at the Company.
- CIN/LLPIN
U85100PN2013PTC148450
- Company No.
148450
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
14 Aug 2013
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Pune
Industry
Company Details
- Location
Pune, Maharashtra, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Shriram Ct Scan & Diagnostics?
Board Members(10)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Prasad Joshi  | Director | 14-Aug-2013 | Current |
| Girish Kakde | Director | 14-Aug-2013 | Current |
| Ratnali Gandhi | Director | 16-Aug-2013 | Current |
| Sanjay Dhumal | Director | 16-Aug-2013 | Current |
| Meghana Barve | Director | 16-Aug-2013 | Current |
| Sachin Gosavi | Director | 16-Aug-2013 | Current |
Financial Performance of Shriram Ct Scan & Diagnostics.
Shriram Ct Scan & Diagnostics Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 63.77% decrease. The company also saw a substantial fall in profitability, with a 115.31% decrease in profit. The company's net worth dipped by a decrease of 3.15%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Shriram Ct Scan & Diagnostics?
Unlock access to Shriram Ct Scan & Diagnostics's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Abhinav Mri & Diagnostics Private LimitedActive 14 years 5 monthsPrasad Joshi, Girish Kakde and 6 more are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Shriram Ct Scan & Diagnostics?
Unlock and access historical data on people associated with Shriram Ct Scan & Diagnostics, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Shriram Ct Scan & Diagnostics, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Shriram Ct Scan & Diagnostics's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
